Roets, M.; Sturgess, D.J.; Wyssusek, K.H.; Lee, S.M.; Dean, M.M.; van Zundert, A.
The Cost of Downstream Adverse Outcomes Associated with Allogeneic Blood Transfusion: A Retrospective Observational Cohort Study. Healthcare 2025, 13, 503.
https://doi.org/10.3390/healthcare13050503
AMA Style
Roets M, Sturgess DJ, Wyssusek KH, Lee SM, Dean MM, van Zundert A.
The Cost of Downstream Adverse Outcomes Associated with Allogeneic Blood Transfusion: A Retrospective Observational Cohort Study. Healthcare. 2025; 13(5):503.
https://doi.org/10.3390/healthcare13050503
Chicago/Turabian Style
Roets, Michelle, David John Sturgess, Kerstin Hildegard Wyssusek, Sung Min Lee, Melinda Margaret Dean, and Andre van Zundert.
2025. "The Cost of Downstream Adverse Outcomes Associated with Allogeneic Blood Transfusion: A Retrospective Observational Cohort Study" Healthcare 13, no. 5: 503.
https://doi.org/10.3390/healthcare13050503
APA Style
Roets, M., Sturgess, D. J., Wyssusek, K. H., Lee, S. M., Dean, M. M., & van Zundert, A.
(2025). The Cost of Downstream Adverse Outcomes Associated with Allogeneic Blood Transfusion: A Retrospective Observational Cohort Study. Healthcare, 13(5), 503.
https://doi.org/10.3390/healthcare13050503